The role of neutrophils in the pathogenesis of obliterative bronchiolitis after lung transplantation
- PMID: 11493399
- DOI: 10.1034/j.1399-3062.2001.003003168.x
The role of neutrophils in the pathogenesis of obliterative bronchiolitis after lung transplantation
Abstract
Obliterative bronchiolitis (OB) represents the most important long-term complication after lung transplantation. Elevated numbers of neutrophils within the airways are a hallmark of OB. It is unclear what causes the recruitment and activation of neutrophils in the airways of patients with OB: the process of chronic rejection itself or infection, which may (especially in latent virus infection) often be overlooked by the currently applied diagnostic procedures. It is well known that besides their physiologic functions in the clearance of invading micro-organisms, activated neutrophils have a remarkable potential to cause damage to lung tissue. This is attributable to their capability to generate reactive oxygen species and to release potentially toxic proteases. It has been shown that the increased numbers of neutrophils in bronchoalveolar lavage fluid of patients with bronchiolitis obliterans syndrome (BOS) after lung transplantation are associated with elevated levels of interleukin-8, the predominant neutrophil chemotactic factor in the lung. As evidence for the impact of neutrophils on the pathogenesis of BOS, there is significant oxidative stress within the airways of patients with BOS. In addition, the milieu within the airways is characterized by an imbalance between neutrophil elastase (NE) and molecules that inhibit NE as a result of an increased burden of NE released by neutrophils. A defective antiprotease shield due to the loss of secretory leukoprotease inhibitor could be demonstrated in BOS. These mechanisms may provide possible targets to develop new therapeutic strategies that either prevent neutrophil sequestration and activation, or inhibit neutrophil products in order to prevent or attenuate airway damage.
Similar articles
-
The presence of a matrix-derived neutrophil chemoattractant in bronchiolitis obliterans syndrome after lung transplantation.J Immunol. 2009 Apr 1;182(7):4423-31. doi: 10.4049/jimmunol.0802457. J Immunol. 2009. PMID: 19299743 Free PMC article.
-
Bronchiolitis obliterans syndrome after (heart-)lung transplantation. Impaired antiprotease defense and increased oxidant activity.Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 1):1640-6. doi: 10.1164/ajrccm.160.5.9902012. Am J Respir Crit Care Med. 1999. PMID: 10556134
-
Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: role of IL-8.J Immunol. 1996 Nov 1;157(9):4194-202. J Immunol. 1996. PMID: 8892657
-
[Pathophysiology of obliterative bronchiolitis in lung transplants].Rev Mal Respir. 2003 Apr;20(2 Pt 1):224-32. Rev Mal Respir. 2003. PMID: 12844020 Review. French.
-
Bronchiolitis obliterans: pathogenesis, prevention, and management.Am J Med Sci. 1998 Mar;315(3):161-78. doi: 10.1097/00000441-199803000-00005. Am J Med Sci. 1998. PMID: 9519929 Review.
Cited by
-
Human neutrophil peptide in lung chronic allograft dysfunction.Biomarkers. 2011 Dec;16(8):663-9. doi: 10.3109/1354750X.2011.623789. Epub 2011 Oct 11. Biomarkers. 2011. PMID: 21988113 Free PMC article.
-
The presence of a matrix-derived neutrophil chemoattractant in bronchiolitis obliterans syndrome after lung transplantation.J Immunol. 2009 Apr 1;182(7):4423-31. doi: 10.4049/jimmunol.0802457. J Immunol. 2009. PMID: 19299743 Free PMC article.
-
Role of CXCR2/CXCR2 ligands in vascular remodeling during bronchiolitis obliterans syndrome.J Clin Invest. 2005 May;115(5):1150-62. doi: 10.1172/JCI24233. J Clin Invest. 2005. PMID: 15864347 Free PMC article.
-
Immune processes in the pathogenesis of chronic lung allograft dysfunction: identifying the missing pieces of the puzzle.Eur Respir Rev. 2022 Jul 27;31(165):220060. doi: 10.1183/16000617.0060-2022. Print 2022 Sep 30. Eur Respir Rev. 2022. PMID: 35896274 Free PMC article. Review.
-
The lectin-like domain of tumor necrosis factor improves lung function after rat lung transplantation--potential role for a reduction in reactive oxygen species generation.Crit Care Med. 2010 Mar;38(3):871-8. doi: 10.1097/CCM.0b013e3181cdf725. Crit Care Med. 2010. PMID: 20081530 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous